Category > Discover Digital Health Startups in Omics Related Diagnosis

Discover Digital Health Startups in Omics Related Diagnosis

As of December 2024, the Omics Related Diagnosis category has a total of 259 Digital Health firms. The total venture volume has expanded at a CAGR of 3.5% over the past 5 years. The ventures have an average venture maturity score of 53.9.

From a funding perspective, these Digital Health companies have successfully raised $10.68B in venture capital investments, channeled through 663 distinct funding rounds. In the past 12 months, total venture capital funding closed at $1.16B across 48 deals.

Last Updated: November 09, 2024

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
3D Medicine (思路迪)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series H	$ 229.02 M
Freenome	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series E	$ 254.00 M
HaploX (海普洛斯)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series D	$ 100.00 M
MiRXES (觅瑞早筛)	Omics Related Diagnosis	Singapore	xyrsttzsas	$ 123.46 B	Series D	$ 50.00 M
BostonGene	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series B	$ 150.00 M
Color Health	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series E	$ 100.00 M
Delfi Diagnostics	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series B1	undisclosed
Human Longevity	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series B3	$ 21.50 M
Gene+ (吉因加)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series C	$ 115.99 M
Genecast (臻和科技)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series E	$ 149.37 M

Showing 1 to 10 of 259 entries